Marengo Therapeutics
PrivateLast Round
Series B
Nov 8, 2021
Total Funding Raised
$119M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Marengo Therapeutics is a biotechnology company that develops precision immunotherapies for cancer and autoimmune diseases through its proprietary T-cell activation platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Marengo Therapeutics Comparables
Compare Marengo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Normunity | 84% | |
| Repertoire Immune Medicines | 82% | |
| Crossbow Therapeutics | 78% |
Marengo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 8, 2021 | ||||
| Series A | Jan 3, 2018 |
Key People
Founding team and executive leadership
Marengo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Apple Tree Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 122% MoM, reaching 4.9K.
- Apr 17, 2026
Unveiled partnered STAR program IPN01203/STAR0501, now in Phase 1 trials.
Recent news
Latest coverage and updates
- hiresAug 6, 2026
Marengo Therapeutics, Inc. hired Saso Cemerski as senior vice president, head of immunology on Aug 6th '26.
Marengo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Marengo Therapeutics's valuation, stock price, and market status.
Is Marengo a public or private company?
Marengo is a private company.
What is the current stock price of Marengo?
Marengo is a private company with no public stock price. No recent secondary market data is available.
How much is Marengo worth (valuation)?
Valuation information for Marengo is not publicly available.
Can I buy Marengo stock?
Marengo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Marengo's last funding round?
Marengo's most recent funding round was Series A on November 8, 2021.
Who are the main investors in Marengo?
Key investors in Marengo include Apple Tree Partners.
Will Marengo IPO soon?
No public IPO plans have been announced for Marengo.
How can I track Marengo secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Marengo's secondary market activity and sign up for updates.